Clinical trials in Hemer – page 3

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies of novel drug combinations and immunotherapy approaches.

• Advanced and Metastatic NSCLC
• Stage II-IIIB Resectable NSCLC
• KRAS G12C Mutations

Research emphasis on combination therapies involving immunotherapy agents and targeted treatments for specific genetic mutations.

Investigations into new treatment approaches for small cell lung cancer (SCLC), particularly focusing on maintenance therapy and immunotherapy combinations.

• Limited Disease SCLC
• Advanced/Metastatic SCLC
• Durvalumab Combinations

Trials evaluating novel therapeutic strategies including chemotherapy with immunotherapy combinations.

Clinical studies examining treatments for various forms of pulmonary fibrosis, including both idiopathic and progressive forms.

• Idiopathic Pulmonary Fibrosis (IPF)
• Progressive Fibrosing ILD
• Long-term Treatment Effects

Focus on improving lung function and evaluating new therapeutic compounds for fibrotic lung diseases.